Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

CME Group Hits 52-Week High On Solid Q2, Sturdy Volumes

Published 08/18/2016, 10:36 PM
Updated 07/09/2023, 06:31 AM

On Aug 18, 2016, shares of CME Group Inc. (NASDAQ:CME) reached a 52-week high of $106.33 driven by strong second-quarter 2016 results. About 0.8 million shares exchanged hands in the last trading session and the stock finally closed at $106.33, up 0.49%. Year to date, the stock has returned 17.35%, which is substantially above 11.74% returned by Nasdaq.

CME Group, in the second quarter, delivered operating earnings per share of $1.14 that surpassed the Zacks Consensus Estimate by 2.70%. The bottom line also improved 15.2% year over year on record average daily volumes (ADV). A record 15.1 million contracts reflected a 13% year-over-year increase. Notably, the company also achieved quarterly record in agricultural commodities. Total average rate per contract inched up 0.6% to 78.2 cents. In fact, ADV improved to 14.1 million contracts per day in July, up 10% year over year.

This Zacks Rank #2 (Buy) securities exchange delivered positive surprises in three of the last four quarters, with an average beat of 2.25%.

Top line too improved 10.5% to a record $906.4 million, driven by 12.6% higher clearing and transaction fees and 3.7% increase in access and communication fees.

Additionally, its open interest reached an all-time high of more than 116 million contracts. This reflects an increased reliance of market participants on CME Group.

CME Group became the first exchange to offer swaptions clearing during the second quarter. This service is aimed to enable clients to obtain greater operational and capital efficiencies from clearing.

In order to help producers and commercial firms to manage their price risk, CME Group undertook initiatives to improve Live Cattle futures markets this August.

Backed by solid earnings, the Zacks Consensus Estimate moved north as most of the estimates were revised higher over the last 30 days. The same increased 3.2% to $4.50 for 2016 and 3% to $4.85 for 2017. The expected long term earnings growth is currently pegged at 9.7%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

CME GROUP INC Price and Consensus

CME GROUP INC Price and Consensus | CME GROUP INC Quote

Other Stocks to Consider

Investors interested in finance sector can also consider stocks like MarketAxess Holdings Inc. (NASDAQ:MKTX) , Bats Global Markets (NYSE:BATS) and Allied World Assurance Company Holdings, AG (NYSE:AWH) . While MarketAxess and Allied World Assurance sport a Zacks Rank #1 (Strong Buy), Bats Global holds a Zacks Rank #2 (Buy).



ALLIED WORLD AS (AWH): Free Stock Analysis Report

CME GROUP INC (CME): Free Stock Analysis Report

MARKETAXESS HLD (MKTX): Free Stock Analysis Report

BATS GLOBAL MKT (BATS): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.